Market Overview

Benzinga's Top Pre-Market Gainers

Related IN
Morning Market Movers
Intermec To Be Acquired by Honeywell for $600M
InMed Pharmaceuticals, Inc. Retains Tiberend Strategic Advisors, Inc. ... (GuruFocus)
Related HON
Credit Suisse Weighs In On Schlumberger, Honeywell
UPDATE: Honeywell Q4 Earnings Beat Views
Dover Dealing With A Very Different Reality (Seeking Alpha)

Intermec (NYSE: IN) moved up 24.37% to $9.90 in the pre-market session. Honeywell International (NYSE: HON) announced its plans to buy Intermec for $600 million.

Cyclacel Pharmaceuticals (NASDAQ: CYCC) soared 6.98% to $6.90 in the pre-market trading. Cyclacel Pharmaceuticals announced updated survival data from the pilot study and lead-in phase of SEAMLESS Phase 3 study.

Celldex Therapeutics (NASDAQ: CLDX) added 6.88% to $5.90 in the pre-market session. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.

Ingersoll-Rand Plc (NYSE: IR) surged 2.28% to $49.80 in the pre-market session. Ingersoll-Rand announced its plans to spin off its security division.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (CLDX + CYCC)

Around the Web, We're Loving...

Get Benzinga's Newsletters